Gapping up
In reaction to earnings/guidance:
- MDLA +5.5%, AMBA +4.3%, LE +4%, SMG +1.2% (raises FY21 EPS and revenue guidance), APPS +1.1%, ZM +1%, DCI +0.9%
Other news:
- ACIU +21.4% (provides key clinical and preclinical updates for its SupraAntigen-derived liposomal vaccine candidates, which are designed to convey active, long-lasting immunization against pathological forms of amyloid-beta)
- AMC +21.4% (unveils all new communication initiative to engage directly with its sizable retail shareholder base through the launch of AMC Investor Connect)
- SLCT +19.4% (FBNC to acquire SLCT in all-stock transaction)
- LYRA +14.8% (Lyra Therapeutics and LianBio form strategic partnership and exclusive license agreement to develop and commercialize LYR-210 in China and other Asian markets)
- SRNE +10.3% (announces that the Mexican Comisión Federal para la Protección contra Riesgos Sanitarios, the health regulatory authority for Mexico, has listed COVI-STIX on its official government website list of rapid antigen tests approved for emergency use in Mexico)
- SKLZ +7.1% (to acquire Aarki)
- LQDA +6.8% (FDA has accepted NDA resubmission for LIQ861 (treprostinil) inhalation powder for treatment of pulmonary arterial hypertension)
- OSTK +3.4% (looking to possibly sell tZERO unit or seek partners, according to CoinDesk)
- AQB +3.1% (reports first harvest of genetically engineered Atlantic salmon)
- INCY +1.9% (Incyte and Eli Lilly (LLY) report OLUMIANT improved pain, physical function and morning joint stiffness in rheumatoid arthritis in Phase 3 post-hoc analyses) SWI +1.7% (aims to be Data Pros' first choice for database performance management, expands comprehensive portfolio with addition of new database insights for SQL server solution)
- KMDA +1.5% (receives FDA approval for KEDRAB label update)
- WSBF +1.4% (declares special dividend of $0.50/sh)
- KODK +1.3% (issues statement in response to New York Attorney General)
- ETSY +1.3% (to acquire Depop for $1.625 bln)
Analyst comments:
- DXC +2.9% (upgraded to Overweight from Equal Weight at Wells Fargo)
- CGC +1.3% (upgraded to Hold from Sell at Canaccord Genuity)
- CCEP +0.9% (upgraded to Overweight from Neutral at JP Morgan)